Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future

Brian Godman, Michael Wilcock, Andrew Martin, Scott Bryson, Christoph Baumgärtel, Tomasz Bochenek , Winne de Bruyn, Ljiljana Sović-Brkičić, Marco D’Agata, Antra Fogele, Anna Coma Fusté, Jessica Fraeyman, Jurij Fürst, Kristina Garuoliene, Harald Herholz, Mikael Hoffmann, Sisira Jayathissa, Hye-Young Kwon, Irene Langner, Marija KalabaEva Andersén Karlsson, Ott Laius, Vanda Markovic-Pekovic, Einar Magnusson, Stuart McTaggart, Scott Metcalfe, Hanne Bak Pedersen, Jutta Piessnegger, Anne Marthe Ringerud, Gisbert W. Selke, Catherine Sermet, Krijn Schiffers, Peter Skiold, Juraj Slabý, Dominik Tomek, Anita Viksna, Agnes Vitry, Corinne Zara, Rickard E Malmström

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
502 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds